These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 3922373

  • 1. Thromboxane synthase inhibition potentiates washed platelet activation by endogenous and exogenous arachidonic acid.
    Patscheke H.
    Biochem Pharmacol; 1985 Apr 15; 34(8):1151-6. PubMed ID: 3922373
    [Abstract] [Full Text] [Related]

  • 2. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
    Patscheke H, Stegmeier K.
    Thromb Res; 1984 Feb 01; 33(3):277-88. PubMed ID: 6424261
    [Abstract] [Full Text] [Related]

  • 3. Transient concentrations and agonist potency of PGH2 in platelet activation by endogenous arachidonate.
    Hornberger W, Patscheke H.
    Eicosanoids; 1989 Feb 01; 2(4):241-8. PubMed ID: 2517034
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Hydrogen peroxide and methyl mercury are primary stimuli of eicosanoid release in human platelets.
    Hornberger W, Patscheke H.
    J Clin Chem Clin Biochem; 1989 Sep 01; 27(9):567-75. PubMed ID: 2481709
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of thromboxane A2 synthetase inhibition, singly and combined with thromboxane A2/prostaglandin endoperoxide receptor antagonism, on inositol phospholipid turnover and on 5-HT release by washed human platelets.
    de Chaffoy de Courcelles D, De Clerck F.
    Eur J Pharmacol; 1990 Mar 13; 188(2-3):161-9. PubMed ID: 2318257
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
    Yu SM, Wu TS, Teng CM.
    Br J Pharmacol; 1994 Mar 13; 111(3):906-12. PubMed ID: 8019768
    [Abstract] [Full Text] [Related]

  • 11. Role of proaggregatory and antiaggregatory prostaglandins in hemostasis. Studies with combined thromboxane synthase inhibition and thromboxane receptor antagonism.
    Gresele P, Arnout J, Deckmyn H, Huybrechts E, Pieters G, Vermylen J.
    J Clin Invest; 1987 Nov 13; 80(5):1435-45. PubMed ID: 2960694
    [Abstract] [Full Text] [Related]

  • 12. Prostaglandins and human platelet aggregation. Implications for the anti-aggregating activity of thromboxane-synthase inhibitors.
    Rajtar G, Cerletti C, Castagnoli MN, Bertelé V, de Gaetano G.
    Biochem Pharmacol; 1985 Feb 01; 34(3):307-10. PubMed ID: 3918536
    [Abstract] [Full Text] [Related]

  • 13. Platelet desensitization induced by arachidonic acid is not due to cyclo-oxygenase inactivation and involves the endoperoxide receptor.
    Carmo LG, Hatmi M, Rotilio D, Vargaftig BB.
    Br J Pharmacol; 1985 Aug 01; 85(4):849-59. PubMed ID: 2994786
    [Abstract] [Full Text] [Related]

  • 14. Pharmacologic inhibition of thromboxane synthetase and platelet aggregation: modulatory role of cyclooxygenase products.
    Bertelé V, Falanga A, Tomasiak M, Chiabrando C, Cerletti C, de Gaetano G.
    Blood; 1984 Jun 01; 63(6):1460-6. PubMed ID: 6426554
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Inhibitory effects of the selective thromboxane receptor antagonist BM 13.177 on platelet aggregation, vasoconstriction and sudden death.
    Patscheke H, Stegmeier K, Müller-Beckmann B, Sponer G, Staiger C, Neugebauer G.
    Biomed Biochim Acta; 1984 Jun 01; 43(8-9):S312-8. PubMed ID: 6097235
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of thromboxane and 12-HPETE formation by dazoxiben and its two thiophenic acid-substituted derivatives.
    Smith EF, Darius H, Ferber H, Schrör K.
    Eur J Pharmacol; 1985 Jun 07; 112(2):161-9. PubMed ID: 3896821
    [Abstract] [Full Text] [Related]

  • 20. Thromboxane-mediated activation of platelets and enhancement of platelet uptake onto collagen-coated glass or deendothelialized rabbit aorta. Comparative effects of a thromboxane antagonist (EPO45) and a thromboxane synthetase inhibitor (dazoxiben).
    Menys VC, Davies JA.
    Lab Invest; 1984 Feb 07; 50(2):184-9. PubMed ID: 6546403
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.